Cost-benefit and effectiveness of nosocomial surveillance methods

Current Clinical Topics in Infectious Diseases

Volumn , Issue 21, 2001, Pages 391-406

  Obasanjo, Olugbenga ^a   Perl, Trish M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; CROSS INFECTION; ECONOMICS; HEALTH SURVEY; HUMAN; INFECTION CONTROL; MEDICAID; METHODOLOGY; MORTALITY; REVIEW; UNITED STATES;

COST-BENEFIT ANALYSIS; CROSS INFECTION; HOSPITAL MORTALITY; HUMANS; INFECTION CONTROL; MEDICAID; SENTINEL SURVEILLANCE; UNITED STATES;

EID: 0035238193     PISSN: 01953842     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (66)

1. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993;6: 428-442.
2. Public health focus: surveillance, prevention, and control of nosocomial infections. Morb Mortal Wkly Rep 1992;41:783-787.
3. Haley R. Surveillance by objective: a new priority-directed approach to the control of nosocomial infections. The National Foundation for Infectious Diseases Lecture. Am J Infect Control 1985;13: 78-89.
4. Pinner RW, Haley RW, Blumenstein BA, et al. High cost of nosocomial infections. Infect Control Hosp Epidemiol 1982;3:143-149.
5. Haley RW, Schaberg DR, Crossley KB, et al. Extra charges and prolongation of stay attributable to nosocomial infections: a prospective interhospital comparison. Am J Med 1981;70:51-58.
6. Haley RW, Schaberg DR, Von Allmen SD, McGowan JE. Estimating the extra charges and prolongation of hospitalization due to nosocomial infections: a comparison of methods. J Infect Dis 1980;141:248-257.
7. Haley RW, Morgan WM, Culver DH, et al. Update from the SENIC project. Hospital infection control: recent progress and opportunities under prospective payment. Am J Infect Control 1985;13:97-108.
8. Wenzel RP. Nosocomial infections, diagnosis-related groups, and study on the efficacy of nosocomial infection control: economic implications for hospitals under the prospective payment system. Am J Med 1985;78(suppl.6B):3-7.
9. Wenzel RP. Towards a global perspective of nosocomial infection. Eur J Clin Microbiol 1987; 6:341-343.
10. Boyce JM, Potter-Bynoe G, Dziobek L. Hospital reimbursement patterns among patients with surgical wound infections following open heart surgery. Infect Control Hosp Epidemiol 1990;11: 89-93.
11. Massanari RM, Wilkerson K, Streed SA, Hierholzer WJJ. Reliability of repotting nosocomial infections in the discharge abstract and implications for receipt of revenues under prospective reimbursement. Am J Public Health 1987;77: 561-564.
12. Miller PJ, Farr BM, Gwaltney JMJ. Economic benefits of an effective infection control program: case study and proposal. Rev Infect Dis 1989;11: 284-288.
13. Perl TM. Surveillance, reporting and the use of computers. In: Wenzel RP, ed. Prevention and control of nosocomial infections. Baltimore: Williams & Wilkins, 1997:127-162.
14. Pottinger JM, Herwaldt LA, Perl TM. Basics of surveillance-an overview. Infect Control Hosp Epidemiol 1997;18:513-527.
15. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-140.
16. Rubin RJ, Harrinton CA, Poon A, et al. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerging Infect Dis 1999;5:1-13.
17. Merle V, Germain JM, Chamouni P, et al. Assessment of prolonged hospital stay attributable to surgical site infections using appropriateness evaluation protocol. Am J Infect Control 2000; 28:109-115.
18. Wakefield DS, Pfaller MA, Hammons GT, Massanari RM. Use of the appropriateness evaluation protocol for estimating the incremental costs associated with nosocomial infections. Med Care 1987;25:481-488.
19. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality [see comments]. JAMA 1994;271:1598-1601.
20. Digiovine B, Chenowcth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999; 160:976-981.
21. VandenBergh MFQ, Kluytmans JAJW, van Hout BA, et al. Cost-effectiveness of perioperative mupirocin nasal ointment in cardiothoracic surgery. Infect Control Hosp Epidemiol 1996;17: 786-792.
22. Givens CD, Wenzel RP. Catheter-associated urinary tract infections in surgical patients: a controlled study on the excess morbidity and costs. J Urol 1980;124:646-648.
23. Zuckerman RA, Steele L, Venezia RA, Tobin EH. Undetected vancomycin-resistant enterococcus in surgical intensive care unit patients. Infect Control Hosp Epidemiol 1999;20:685-686.
24. Martin MA, Pfaller MA, Wenzel RP. Coagulasc-negative staphylococcal bacteremia. Mortality and hospital stay [see comments]. Ann Intern Med 1989;110:9-16.
25. Cao L. Cost of nosocomial infections in Wuhan No. 4 Hospital, China [letter]. Infect Control Hosp Epidemiol 2000;21:4-5.
26. Green JW, Wenzel RP. Postoperative wound infection: a controlled study of the increased duration of hospital stay and direct cost of hospitalization. Arch Surg 1977;185:264-268.
27. Spengler RF, Greenough WB. Hospital costs and mortality attributed to nosocomial bacteremias. JAMA 1978;240:2455-2459.
28. Wakefield DS, Helms CM, Massanari RM, et al. Cost of nosocomial infection: relative contributions of laboratory, antibiotic, and per diem costs in serious Staphylococcus aureus infections. Am J Infect Control 1988;16:185-192.
29. Wilcox MH, Dave J. The cost of hospital-acquired infection and the value of infection control. J Hosp Infect 2000;45:81-84.
30. Kirkland KB, Briggs JP, Trivette SL, et al. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs [see comments]. Infect Control Hosp Epidemiol 1999;20:725-730.
31. Chrischilles EA, Scholz DA. Dollars and sense: a practical guide to cost analysis for hospital epidemiology and infection control. Clin Perform Qual Health Care 1999;7:107-111.
32. Mundy LM, Fraser VJ. Determining the cost-effectiveness of hospital epidemiology and infection control programs. In: Mayhall CG, ed. Hospital epidemiology and infection control, vol. I. Philadelphia: Williams and Wilkins, 1999: 1437-1443.
33. Davey P, Hemanez C, Lynch W, et al. Human and non-financial costs of hospital-acquired infection. J Hosp Infect 1991;18:79-84.
34. Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985;121:182-205.
35. Scheckler WE, Brimhall D, Buck AS, et al. Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Society for Healthcare Epidemiology of America. Am J Infect Control 1998;26:47-60.
36. Wenzel RP. The Lowbury lecture. The economics of nosocomial infections. J Hosp Infect 1995; 31:79-87.
37. Detsky AS, Naglie IG. A clinician's guide to cost-effectiveness analysis. Ann Intern Med 1990; 113:147-154.
38. Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C. Control of endemic methieillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999;282: 1745-1751.
39. Landry SL, Donowitz LG, Wenzel RP. Hospitalwide surveillance: perspective for the practitioner. Am J Infect Control 1982;10:66-67.
40. Cruse PJE, Foord R. A five-year prospective study of 23,649 surgical wounds. Arch Surg 1973; 107:206-210.
41. Cruse PJE, Foord R. The epidemiology of wound infection: a 10-year prospective study of 62,939 wounds. Surg Clin North Am 1980;60:27-39.
42. Jernigan JA, Clemence MA, Stott GA, et al. Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 1995;16:686-696.
43. Karanfil LV, Conlon M, Lykens K, et al. Reducing the rate of nosocomially respiratory syncytial virus. Am J Infect Control 1999;27:91-96.
44. Macartney KK, Corellek MH, Manning ML, et al. Nosocomial respiratory syncytial virus infections: the cost-effectiveness and cost-benefit of infection control. Pediatrics 2000;106:520-526.
45. Kelleghan SI, Salemi C, Padilla S, et al. An effective continuous quality improvement approach to the prevention of ventilator-associated pneumonia. Am J Infect Control 1993;21:322-330.
46. Kureisha A, MacPhail G, O'Neill L, Lam Li D. The direct cost of controlling an outbreak of vancomycin resistant enterococci (VRE) at a Canadian tertiary care trauma centre. San Francisco, CA: Interscience Conference Antimicrobial Agents Chemotherapy, 1997.
47. Spearing NM, Jensen A, McCall BJ, et al. Direct costs associated with a nosocomial outbreak of Salmonella infection: an ounce of prevention is worth a pound of cure. Am J Infect Control 2000;28: 54-57.
48. Wenzel R, Osterman C, Hunting K, Gwaltney JJ. Hospital acquired infections. I. Surveillance in a university hospital. Am J Epidemiol 1976;103: 251-260.
49. Parkhurst SM, Blaser MJ, Laxson LB, Wang WL. Surveillance for the detection of nosocomial infections and the potential for nosocomial outbreaks. II. Development of a laboratory-based system. Am J Infect Control 1985;13:7-15.
50. Laxson LB, Blaser MJ, Parkhurst SM. Surveillance for the detection of nosocomial infections and the potential for nosocomial outbreaks. I. Microbiology culture surveillance is an effective method of detecting nosocomial infection. Am J Infect Control 1984;12:318-324.
51. Bartlett CL. Efficacy of different surveillance systems in detecting hospital-acquired infections. Chemiotherapia. 1987;6:152-155.
52. Gross PA, Beaugard A, Van Antwerpen C. Surveillance for nosocomial infections: can the sources of data be reduced? Infect Control 1980;1:233-236.
53. Haley RW, Schaberg DR, McClish DK, et al. The accuracy of retrospective chart review in measuring nosocomial infection rates. Am J Epidemiol 1980;111:516-533.
54. Ford-Jones EL, Mindorff CM, Pollock E, et al. Evaluation of a new method of detection of nosocomial infection in the pediatric intensive care unit: the infection control sentinel sheet system. Infect Control Hosp Epidemiol 1989;10:515-520.
55. Lima NL, Pereira CRB, Souza IC, et al. Selective surveillance for nosocomial infections in a Brazilian hospital. Infect Control Hosp Epidemiol 1993;14:197-202.
56. Freeman J, McGowan JEJ. Methodologie issues in hospital epidemiology. I. Rates, case-finding, and interpretation. Rev Infect Dis 1981;3:658-667.
57. Glenister H, Tayor L, Bartlett C, et al. An assessment of selective surveillance methods for detecting hospital-acquired infection. Am J Med 1991;91(suppl 3B):121S-124S.
58. Chelgren G, LaForce FM. Limited, periodic surveillance proves practical and effective. Hospitals 1978;52:151-152,154.
59. Yokoe DS, Anderson J, Chambers R, et al. Simplified surveillance for nosocomial bloodstream infections. Infect Control Hosp Epidemiol 1998; 19:657-660.
60. Smyth ET, McIlvenny G, Barr JG, et al. Automated entry of hospital infection surveillance data. Infect Control Hosp Epidemiol 1997;18:486-491.
61. Broderiek A, Mori M, Nettleman MD, et al. Nosocomial infections: validation of surveillance and computer modeling to identify patients at risk. Am J Epidemiol 1990;131:734-742.
62. Sands K, Vineyard G, Livingston J, et al. Efficient identification of postdischarge surgical site infections: use of automated pharmacy dispensing information, administrative data, and medical record information. J Infect Dis 1999;179:434-441.
63. Goodman RA, Solomon SL. Transmission of infectious diseases in outpatient health care settings. JAMA 1991;265:2377-2381.
64. Sands K, Vineyard G, Platt R. Surgical site infections occurring after hospital discharge. J Infect Dis 1996;173:963-970.
65. Hirschhorn LR, Currier JS, Platt R. Electronic surveillance of antibiotic exposure and coded discharge diagnoses as indicators of postoperative infection and other quality assurance measures. Infect Control Hosp Epidemiol 1993;14:21-28.
66. Onesko K, Wienke E. The analysis of the impact of a mild, low-iodine, lotion soap on the reduction of nosocomial methicillin-resistant Staphylococcus aureus: a new opportunity for surveillance by objectives. Infect Control 1987;8:284-288.